NASDAQ: ELEV - Elevation Oncology, Inc.

Yield per half year: -45.7%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Elevation Oncology, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Elevation Oncology, Inc.

Elevation Oncology, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке терапевтических средств для лечения рака у генетически определенных популяций пациентов в Соединенных Штатах. Его ведущей программой является серибантумаб, моноклональное антитело против HER3, которое находится в фазе II испытания CRESTONE для лечения запущенных солидных опухолей, содержащих слияние нейрегулина-1. Компания была зарегистрирована в 2019 году и базируется в Нью-Йорке, штат Нью-Йорк.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-06-25
ISIN US28623U1016
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.elevationoncology.com
Цена ао 0.2831
Change price per day: +3.7% (0.27)
Change price per week: +12% (0.25)
Change price per month: -45.11% (0.5101)
Change price per 3 month: -56.95% (0.6504)
Change price per half year: -45.7% (0.5157)
Change price per year: -94.08% (4.73)
Change price per 3 year: -88.76% (2.49)
Change price per year to date: -52.82% (0.5935)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.5368 10
P/E 0.17 10
EV/EBITDA -0.3108 0
Total: 6.25

Efficiency

Title Value Grade
ROA, % -48.17 0
ROE, % -77.48 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.6965 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 158.98 10
Yield EPS, % -25.32 0
Total: 6
More

Institutions Volume Share, %
Farallon Capital Management Llc 4 7.11
Point72 Asset Management, L.P. 3 6.16
Tang Capital Management, LLC 3 5.6
Balyasny Asset Management LLC 3 5.59
Aisling Capital Management LP 3 5.19
venBio Partners LLC 3 4.93
Braidwell LP 2 4.35
Darwin Global Management, Ltd. 2 4.27
BVF Inc. 2 4.23
Citadel Advisors Llc 2 2.87



Head Job title Payment Year of birth
Mr. Joseph J. Ferra Jr. CEO, President & Director 391.52k 1975 (50 years)
Ms. Tammy Furlong CPA, P.M.P. CFO & Secretary N/A 1971 (54 years)
Ms. Valerie Malyvanh Jansen M.D., Ph.D. Chief Medical Officer 641.53k 1978 (47 years)
Dr. David Dornan Ph.D. Chief Scientific Officer 545.5k 1978 (47 years)
Candice Masse Senior Director of Corporate Communications & Investor Relations N/A
Mr. Robert C. Yang Vice President of Legal Affairs N/A
Mr. Ryan Bloomer Head of Tech Ops N/A
Mr. Biren Shah Senior Vice President of Business & Corporate Development

Address: United States, New York. NY, 888 Seventh Avenue - open in Google maps, open in Yandex maps
Website: https://www.elevationoncology.com